Beckman Coulter Life Sciences announced a strategic partnership with Automata to integrate Beckman liquid‑handling, genomic and cell‑analysis instruments into Automata’s AI‑ready LINQ automation ecosystem. The collaboration includes Danaher Ventures’ participation in Automata’s Series C and a seat on Automata’s board. The tie aims to create modular, cloud‑orchestrated workcells and produce structured, high‑quality datasets optimized for AI‑driven discovery. Automata separately closed a $45 million Series C round—including Danaher strategic investment—to scale deployments and build closed‑loop experimentation software. For lab operations and biotechs, the combined funding and partnership accelerate adoption pathways for autonomous wet‑lab platforms and highlight vendor consolidation linking traditional instrument makers with nimble automation software companies. The pact could shorten translational timelines by improving reproducibility and throughput for screening and early discovery work.